About
Future Fertility is a medtech AI company revolutionizing oocyte quality assessment in reproductive medicine. Leveraging the industry's largest and most diverse egg image dataset, their non-invasive AI models deliver objective, standardized evaluations of egg quality that go far beyond traditional age-based or count-based assessments. Their suite of tools includes VIOLET™ for egg freezing cycles, MAGENTA™ for IVF treatment planning, and ROSE™ purpose-built for donor egg programs and egg banks. These solutions integrate seamlessly into existing clinic workflows, enabling embryologists and reproductive specialists to provide patients with unprecedented personalized insights at every stage of their fertility journey. For patients, the MyFutureFertility platform translates complex AI assessments into clear, actionable reports—empowering individuals to understand their unique egg quality and engage more meaningfully with their care teams. Future Fertility's models have been clinically validated in partnership with leading fertility clinics globally, with findings published in peer-reviewed journals and presented in over 65 scientific abstracts. The platform is currently trusted by more than 300 partner clinics across 35+ countries, setting a new standard for objectivity and consistency in reproductive medicine. Ideal users include fertility clinic labs, IVF specialists, donor egg programs, egg banks, and patients seeking deeper insight into their reproductive potential.
Key Features
- AI Oocyte Quality Scoring: Non-invasive image-based AI models evaluate individual egg quality objectively, moving beyond age and count as the only predictors of fertility outcomes.
- Multi-Product Suite (VIOLET™, MAGENTA™, ROSE™): Specialized tools for egg freezing cycles, IVF treatment planning, and donor egg program optimization—each tailored to specific clinical contexts.
- MyFutureFertility Patient Portal: A patient-facing platform that translates AI-generated assessments into clear, personalized reports to support informed decision-making throughout the fertility journey.
- Seamless Clinic Integration: Designed to integrate directly into existing embryology lab workflows, enabling standardized oocyte assessment without disrupting daily operations.
- Clinically Validated Science: AI models developed and validated in partnership with leading fertility clinics, backed by peer-reviewed publications and 65+ scientific abstracts.
Use Cases
- Fertility clinics using AI-generated oocyte quality scores to personalize IVF and egg freezing treatment plans for individual patients.
- Egg banks and donor egg programs leveraging ROSE™ to optimize oocyte distribution based on objective quality data rather than subjective grading.
- Multi-location fertility clinic groups standardizing oocyte assessment quality across all sites to ensure consistent patient care.
- Patients undergoing egg freezing or IVF receiving personalized quality reports to better understand their reproductive potential and treatment options.
- Reproductive medicine researchers using Future Fertility's AI-driven data to study correlations between oocyte morphology and clinical outcomes.
Pros
- Objective, Standardized Assessment: Eliminates subjective variability in oocyte grading across clinicians and lab staff, enabling consistent quality standards across multi-site operations.
- Broad Global Adoption: Trusted by 300+ clinics in 35+ countries, demonstrating real-world clinical applicability and scalability across diverse patient populations.
- Patient-Centered Insights: Personalized patient reports empower individuals with meaningful data about their unique egg quality, improving engagement and treatment adherence.
- Peer-Reviewed Validation: Strong scientific credibility with findings published in peer-reviewed journals and presented at major reproductive medicine conferences.
Cons
- Enterprise-Focused Pricing: Primarily targeted at fertility clinics and egg banks—pricing and access are not transparent or self-serve, which may limit adoption for smaller practices.
- Niche Application Domain: Highly specialized for reproductive medicine; has no applicability outside fertility and IVF contexts.
- Requires Clinical Integration: Full value is realized only when integrated into an existing clinic's lab workflow, which may require IT coordination and onboarding time.
Frequently Asked Questions
What is Future Fertility and what problem does it solve?
Future Fertility is an AI medtech company that provides tools to objectively assess oocyte (egg) quality during fertility treatments. Traditionally, egg quality was estimated using age and quantity alone—Future Fertility's AI adds a new dimension by analyzing egg images to provide individualized quality scores.
What are VIOLET™, MAGENTA™, and ROSE™?
These are Future Fertility's core AI products: VIOLET™ is designed for egg freezing cycles, MAGENTA™ supports IVF treatment planning, and ROSE™ is purpose-built for donor egg programs and egg banks to optimize oocyte distribution.
How does Future Fertility's AI work?
The AI analyzes microscopic images of oocytes using models trained on the industry's largest and most diverse egg image dataset. It delivers objective quality scores without any invasive procedures, integrating directly into the lab's existing workflow.
Is Future Fertility's technology clinically validated?
Yes. Future Fertility's AI models have been validated in partnership with leading fertility clinics worldwide, with results published in peer-reviewed journals and presented in over 65 scientific abstracts.
How can patients access their results?
Patients whose clinics use Future Fertility's tools can access their personalized egg quality reports through the MyFutureFertility patient insights platform, which presents complex AI data in a clear and actionable format.
